Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 110,000 shares at $113.35 ($12.6M) on 2024-10-01, disclosed to the SEC on 2024-10-03.
Scheduled sale ($12.6M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.35 | 4,305 | $488K | 3.9% |
| 2 | $113.35 | 4,305 | $488K | 3.9% |
| 3 | $113.37 | 4,899 | $555K | 4.4% |
| 4 | $113.37 | 4,899 | $555K | 4.4% |
| 5 | $113.38 | 3,624 | $411K | 3.3% |
| 6 | $113.38 | 3,624 |
| $411K |
| 3.3% |
| 7 | $114.20 | 9,429 | $1.1M | 8.6% |
| 8 | $114.20 | 9,429 | $1.1M | 8.6% |
| 9 | $114.27 | 7,088 | $810K | 6.4% |
| 10 | $114.27 | 7,088 | $810K | 6.4% |
| 11 | $114.28 | 9,627 | $1.1M | 8.8% |
| 12 | $114.28 | 9,627 | $1.1M | 8.8% |
| 13 | $114.93 | 6,266 | $720K | 5.7% |
| 14 | $114.93 | 6,266 | $720K | 5.7% |
| 15 | $114.98 | 5,474 | $629K | 5.0% |
| 16 | $114.98 | 5,474 | $629K | 5.0% |
| 17 | $114.99 | 4,288 | $493K | 3.9% |
| 18 | $114.99 | 4,288 | $493K | 3.9% |
| Total | $114.25 avg | 110,000 | $12.6M | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |